Strategies & Technologies Driving Drug Discovery to Market
Researchers Identify Genes for Thiostrepton
March 25, 2009 4:08 am | News | CommentsResearchers at the Georgia Institute of Technology have identified the genetic machinery responsible for synthesizing thiostrepton, an antibiotic produced by certain bacteria.
ACD/Labs and Pharma Algorithms Join Forces
March 24, 2009 1:03 pm | News | CommentsAdvanced Chemistry Development, Inc., (ACD/Labs) and Pharma Algorithms, Inc., have joined software development and business resources to provide in silico physicochemical, ADME, metabolism, and toxicology screening and prediction tools.
Hollow Gold Nanospheres Target Cancer Cells
March 24, 2009 12:30 pm | News | CommentsA new metal nanostructure has shown promise in cancer therapy studies and could be used for chemical and biological sensors and other applications as well.
Biochemists Create New Protein from Scratch
March 24, 2009 12:07 pm | News | CommentsUsing design and engineering principles learned from nature, a team of biochemists from the University of Pennsylvania School of Medicine have built—from scratch—a completely new type of protein.
Cancer Drug Offers Hope for Dogs and Humans
March 24, 2009 11:49 am | News | CommentsPets with cancer provide a win-win opportunity for cancer researchers. Researchers can study new cancer treatments in animals other than lab mice. And pets get access to new treatments that provide hope.
Collaboration News Briefs - March 9-13
March 23, 2009 11:42 am | News | CommentsCollaboration highlights including companies such as: AMDL, Inc., Entelos, Teikoku Pharma USA, Applied Biosystems, GE Healthcare, and more.
Collaboration News Briefs - March 2-6
March 23, 2009 9:54 am | News | CommentsCollaboration news highlights including companies such as: InterMed Discovery, Bristol-Myers Squibb, Tecan, GE Healthcare, Complete Genomics, StemCells Inc., and more.
Gold Nanospheres Show Promise for Biomedical Applications
March 23, 2009 8:35 am | News | CommentsA new metal nanostructure developed by researchers at the University of California, Santa Cruz, has already shown promise in cancer therapy studies and could be used for chemical and biological sensors and other applications as well.
Molecular Fingerprints Point the Way to Earlier Cancer Diagnosis
March 23, 2009 8:02 am | News | CommentsMetabolites are molecular fingerprints of what your cells are up to and Dr. Arun Sreekumar wants to know the impression made by cancer.
Cellular Process Found that Fights Herpes Virus
March 23, 2009 7:35 am | News | CommentsScientists have discovered a new way for our immune system to combat the elusive virus responsible for cold sores: Type 1 herpes simplex (HSV-1).
MDRNA Signs Licensing Deal with Novartis
March 23, 2009 7:23 am | News | CommentsMDRNA, Inc. announced that it has entered into a licensing agreement with Novartis for MDRNA's liposomal technology platform for siRNA delivery.
Life Technologies and Nanosys Enter Into Quantum Dot Licensing Deal
March 23, 2009 7:15 am | News | CommentsLife Technologies Corporation and Nanosys announced a cross-licensing agreement to share rights to an intellectual property estate related to fluorescent nanocrystals (also known as quantum dots).
Ten Genes Associated With Risk Factor for Sudden Cardiac Death Identified
March 23, 2009 5:15 am | News | CommentsHaving identified 10 common variants of genes that modify the timing of the contraction of the heart, scientists in the Johns Hopkins University School of Medicine, now provide new insight about the underpinnings of the QT interval which, when prolonged or shortened, predisposes to sudden cardiac death.
Bifantis Able to Claim Efficacy for IBS Symptoms
March 23, 2009 4:44 am | News | CommentsA review by researchers at Northwestern University and University of Michigan of the utility of probiotics in the treatment of Irritable Bowel Syndrome (IBS) found that Bifidobacterium infantis 35624 was the only probiotic strain out of 13 different individual strains or preparations reviewed to significantly improve symptoms of IBS.
FDA Approves Symbyax
March 23, 2009 4:30 am | News | CommentsEli Lilly and Company announced that the FDA has approved a new indication for Symbyax (olanzapine and fluoxetine HCl capsules).
